Cargando…

Pathogenic CD8 T Cells in Multiple Sclerosis and Its Experimental Models

A growing body of evidence suggests that autoreactive CD8 T cells contribute to the disease process in multiple sclerosis (MS). Lymphocytes in MS plaques are biased toward the CD8 lineage, and MS patients harbor CD8 T cells specific for multiple central nervous system (CNS) antigens. Currently, ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huseby, Eric S., Huseby, Priya G., Shah, Shivanee, Smith, Rebecca, Stadinski, Brian D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341980/ https://www.ncbi.nlm.nih.gov/pubmed/22566945 http://dx.doi.org/10.3389/fimmu.2012.00064

Ejemplares similares

A Pathogenic Role for Myelin-Specific Cd8(+) T Cells in a Model for Multiple Sclerosis
por: Huseby, Eric S., et al.
Publicado: (2001)

Neonatal-derived IL-17 producing dermal γδ T cells are required to prevent spontaneous atopic dermatitis
por: Spidale, Nicholas A, et al.
Publicado: (2020)

Involvement of CD8(+) T Cells in Multiple Sclerosis
por: Salou, Marion, et al.
Publicado: (2015)

CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis
por: Sinha, Sushmita, et al.
Publicado: (2015)

Role of T cell—glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms
por: Huseby, Eric S., et al.
Publicado: (2015)

Hydrophobic CDR3 residues promote the development of self-reactive T cells
por: Stadinski, Brian D., et al.
Publicado: (2016)

The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017)

Activation of Blood CD3(+)CD56(+)CD8(+) T Cells during Pregnancy and Multiple Sclerosis
por: de Andrés, Clara, et al.
Publicado: (2017)

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis
por: Acquaviva, Massimo, et al.
Publicado: (2019)

Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells
por: Tilly, Gaëlle, et al.
Publicado: (2021)

Tolerating the Nervous System: A Delicate Balance
por: Huseby, Eric S., et al.
Publicado: (2000)

The Rotating Front Row Increases Student-Reported Participation during Discussion
por: Huseby, Medora
Publicado: (2022)

Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis
por: Liu, Pen-Ju, et al.
Publicado: (2023)

Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2019)

CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease?
por: Stojić-Vukanić, Zorica, et al.
Publicado: (2020)

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
por: de Sèze, Jérôme, et al.
Publicado: (2023)

CXCR5+ CD8 T Cells: Protective or Pathogenic?
por: Valentine, Kristen M., et al.
Publicado: (2019)

Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota
por: van den Hoogen, Ward J., et al.
Publicado: (2017)

The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
por: Veroni, Caterina, et al.
Publicado: (2021)

Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain
por: Gargano, Francesca, et al.
Publicado: (2022)

αβ T cell receptors as predictors of health and disease
por: Attaf, Meriem, et al.
Publicado: (2015)

Affinity for self antigen selects regulatory T cells with distinct functional properties
por: Wyss, Lena, et al.
Publicado: (2016)

Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
por: Lassmann, Hans
Publicado: (2019)

Phenotypic Alterations Involved in CD8+ Treg Impairment in Systemic Sclerosis
por: Negrini, Simone, et al.
Publicado: (2017)

Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
por: Peeters, Liesbet M., et al.
Publicado: (2017)

The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis
por: Ignatius Arokia Doss, Prenitha Mercy, et al.
Publicado: (2015)

Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis
por: Rossi, Barbara, et al.
Publicado: (2016)

Heritable Gene Regulation in the CD4:CD8 T Cell Lineage Choice
por: Issuree, Priya D. A., et al.
Publicado: (2017)

Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis
por: Consuegra-Fernández, Marta, et al.
Publicado: (2017)

Vitamin D/CD46 Crosstalk in Human T Cells in Multiple Sclerosis
por: Killick, Justin, et al.
Publicado: (2020)

Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8(+) T Cell Responses
por: Shaw, Tovah N., et al.
Publicado: (2019)

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Clemente, Nausicaa, et al.
Publicado: (2017)

Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Arellano, Gabriel, et al.
Publicado: (2015)

Mass Cytometry Identifies Expansion of T-bet(+) B Cells and CD206(+) Monocytes in Early Multiple Sclerosis
por: Couloume, Laura, et al.
Publicado: (2021)

Brain Antigens Stimulate Proliferation of T Lymphocytes With a Pathogenic Phenotype in Multiple Sclerosis Patients
por: Gottlieb, Assaf, et al.
Publicado: (2022)

Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models
por: Deerhake, M. Elizabeth, et al.
Publicado: (2019)

Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen
por: Lumley, Sheila F., et al.
Publicado: (2018)

Myelin-Specific Cd8 T Cells in the Pathogenesis of Experimental Allergic Encephalitis and Multiple Sclerosis
por: Steinman, Lawrence
Publicado: (2001)

CD8(+) T Cell Tolerance to a Tumor-associated Antigen Is Maintained at the Level of Expansion Rather than Effector Function
por: Öhlén, Claes, et al.
Publicado: (2002)

Interleukin-17D Promotes Pathogenicity During Infection by Suppressing CD8 T Cell Activity
por: Lee, Younghee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pfmjcje9cdksord6jhcc3o3e9e